HIV therapies / immune systems / impaired immune systems / animal model systems / blood products / treatment of head and neck cancers / pharmaceutical manufacturers / weakened immune systems / normal immune systems / /
MedicalCondition
dry cough / unexplained fever / acquired immunodeficiency syndrome / PCP disease / Pneumocystis carinii cysts / MS / head cancers / fungal infections / Pneumocystis Pneumonia / cancer / opportunistic infections / disease / shortness of breath / serious disease / Pneumocystis carinii pneumonia / health epidemic / et al. Pneumocystis Pneumonia / PCP epidemic / AIDS / neck cancers / infection / severe infectious diseases / syndrome / common opportunistic infection / /
MedicalTreatment
first AIDS / anti-retroviral therapy / antibiotics / alternative therapy / HAART / antibiotic therapies / antibiotic therapy / /
Organization
National Cancer Institute / National Institute of Health / Food and Drug Administration / National Institutes of Health office of Technology Transfer Page / Center for Disease Control / Public Health Service / FDA / NIH office of Technology Transfer / Clinical Center / /
Neutrexin New Life from an Old Drug: A Case Study Patients with impaired immune systems often suffer “opportunistic infections”(mild to severe infectious diseases) i. People who are at the greatest risk of contrac